1. Home
  2. LKFN vs VCEL Comparison

LKFN vs VCEL Comparison

Compare LKFN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

HOLD

Current Price

$57.25

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$32.94

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKFN
VCEL
Founded
1872
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2009
1996

Fundamental Metrics

Financial Performance
Metric
LKFN
VCEL
Price
$57.25
$32.94
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$67.00
$57.75
AVG Volume (30 Days)
143.0K
577.3K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
3.49%
N/A
EPS Growth
10.47
60.00
EPS
1.04
N/A
Revenue
$985,000.00
$276,259,000.00
Revenue This Year
$15.50
$19.40
Revenue Next Year
$5.51
$18.24
P/E Ratio
$55.86
N/A
Revenue Growth
N/A
16.45
52 Week Low
$54.36
$28.95
52 Week High
$69.38
$45.97

Technical Indicators

Market Signals
Indicator
LKFN
VCEL
Relative Strength Index (RSI) 36.36 43.49
Support Level $55.37 $30.41
Resistance Level $61.80 $34.77
Average True Range (ATR) 1.70 2.05
MACD -0.56 -0.35
Stochastic Oscillator 1.96 12.24

Price Performance

Historical Comparison
LKFN
VCEL

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: